USPTO serial 79407723
MEDIPHORUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 19, 2026
- Examiner
- STADELI, MARTA ANN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MEDIPHORUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty Ward and Smith, P.A.751 Corporate Center Drive, Suite 300Post Office Box 33009Raleigh, NC 27636-3009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic publications in the nature of books, magazines and brochures all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations, recorded on computer media; downloadable electronic publications the nature of books, magazines and brochures all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; downloadable digital media in the nature of downloadable webcasts, downloadable webinars, downloadable video recordings and downloadable multimedia files containing videos, audio, texts and infographics all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; downloadable video and audio recordings all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; downloadable electronic reports, books, leaflets, information sheets, newsletters, and journals all in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; none of the aforesaid goods including, relating to, or in the field of ratings or reviews | ACTIVE | — |
| 035 | Business development services; business advisory services relating to product development; business project management for others in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; business management consultancy; corporate business management consultancy; commercial management consultancy; business consultancy; providing business information; market research; business services, namely, formulation of best practices for the sale, use and application of medical technology and medical devices in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; expert evaluations and reports relating to business matters; business evaluation consultation services related to benchmarking programmes; providing business benchmarking information services; conducting business and market research surveys; collection of market research information; analysis of market research data and statistics; computerised market research services; preparation of business reports; provision of marketing reports; preparation of marketing reports and conducting marketing studies; promoting collaboration within the scientific and research communities to achieve advances in the field of medical technology and medical devices; promoting collaboration within the scientific and research communities to achieve advances in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; promoting the exchange of information within the scientific and research communities to achieve advances in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; business research; business research consultation; business consultancy to the healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceutical industries; business introduction services, namely, business networking; business project management services; business project management services for others, namely, organizing collaborative projects for business purposes in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; arranging and conducting events, namely, organising business networking events in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; none of the aforesaid services including, relating to, or in the field of ratings or reviews | ACTIVE | — |
| 041 | Arranging and conducting seminars, workshops, educational conferences, teleconferences, web conferences and educational and entertainment events, all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; arranging and conducting seminars, workshops, educational conferences, teleconferences and educational and entertainment events all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; education services, namely, organisation of working groups, research groups and educational conventions all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; educational services, namely, arranging and conducting meetings being workshops, conferences, teleconferences, video conferences, non-downloadable webinars and seminars, in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals industries; educational services, namely, arranging and conducting meetings being educational conferences, teleconferences, video conferences, non-downloadable webinars, seminars and workshops in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals industries; educational services, namely, arranging and conducting meetings being educational conferences, teleconferences, video conferences, non-downloadable webinars, seminars and workshops to discuss best practices on a wide range of quality, engineering and organisational subjects within the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; business training services; providing online training in the form of courses, seminars and workshops in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; providing an in-person educational forum in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; providing online electronic publications, not downloadable, in the nature of electronic newsletters in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; providing online non-downloadable electronic newsletters in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals for use by medical technology manufacturers and organisations; providing online non-downloadable electronic reports in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; digital video, audio, and multimedia publishing services for use by medical technology manufacturers and organisations; digital video, audio, and multimedia publishing in relation to regulatory matters, scientific matters, business information, product development, product supply chain, healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals industry and technology; education services, namely, providing tutoring and training courses in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; providing an in-person educational forum in the field of business related to healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals industries; arranging and conducting business conferences in the field of medical technology and medical devices; none of the aforesaid services including, relating to, or in the field of ratings or reviews | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals research and development; industrial analysis and research services in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals research and development; technological consultancy in the field of biotechnology, pharmaceutical, medical technology and medical device research and development; scientific consultancy in the fields of biotechnology, pharmaceutical, life sciences, medical technology and medical device research and development; technical consultancy in the field of environmental science; product design and development in the field of biotechnology, pharmaceuticals, medical devices and medical technology; technology road-mapping, namely, technological planning and consulting services to determine technological need, identify new technology or existing technology, model technological solutions, match technological solutions to technological need, and track the performance of technology in the field biotechnology, pharmaceuticals, medical devices and medical technology; research services, namely, organizing collaborative research projects in the nature of scientific and technological research consulting in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; providing medical and scientific research information in the fields of healthcare delivery, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; product quality evaluation; advisory services relating to the testing of safety of products being consumer product safety testing consultation; advisory services relating to energy efficiency, namely, consulting services in the fields of energy measurement to improve energy efficiency; advisory services relating to obtaining quality systems from organisations, namely, developing quality control standards for research studies in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals, including the documentation of processes, procedures and responsibilities for achieving quality policies and objectives; quality control for others, namely, auditing of the quality control capability of manufacturers; advisory services relating to quality control of manufactured goods; product quality evaluation, namely, evaluation of quality performance of products against bench-mark references; project management of scientific research projects; scientific consultancy services, namely, organizing collaborative projects being technological and scientific research projects concerning scientific issues in the fields of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology and biopharmaceuticals; none of the aforesaid services including, relating to, or in the field of ratings or reviews | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOPHORUM OPERATIONS GROUP LIMITED
- Other trademarks owned by BIOPHORUM OPERATIONS GROUP LIMITED
- Other trademarks owned by BIOPHORUM OPERATIONS GROUP LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named MEDIPHORUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 3, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 19, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 19, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 19, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 19, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 9, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 31, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 23, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 9, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 22, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 22, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 22, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 26, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 26, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Nov 8, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 7, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 1, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 1, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 1, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |